share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 12 09:56
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more